The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(1-Methyl-1H-indol-3-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone ID: ALA1834567
PubChem CID: 56657919
Max Phase: Preclinical
Molecular Formula: C21H21NO4
Molecular Weight: 351.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(/C=C/C(=O)c2cn(C)c3ccccc23)cc(OC)c1OC
Standard InChI: InChI=1S/C21H21NO4/c1-22-13-16(15-7-5-6-8-17(15)22)18(23)10-9-14-11-19(24-2)21(26-4)20(12-14)25-3/h5-13H,1-4H3/b10-9+
Standard InChI Key: ZRPMELYRKOUIQV-MDZDMXLPSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
5.3545 -15.9583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5679 -16.7543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3665 -16.9660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9307 -15.3741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7288 -15.5841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9481 -16.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7788 -16.4171 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0693 -15.6395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4187 -15.1238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2350 -17.1044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4565 -14.3010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1852 -13.9201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7407 -13.8905 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9008 -14.3305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6151 -13.9171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3342 -14.3517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0354 -13.8974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0240 -13.0731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3008 -12.6755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5978 -13.0987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7279 -12.6528 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7136 -11.8289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7580 -14.2833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4576 -13.8483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3778 -11.8565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5625 -11.5837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14 15 1 0
5 4 2 0
15 16 2 0
6 7 1 0
16 17 1 0
7 8 1 0
17 18 2 0
8 9 2 0
18 19 1 0
9 5 1 0
19 20 2 0
20 15 1 0
4 1 1 0
7 10 1 0
5 6 1 0
9 11 1 0
11 12 1 0
2 3 1 0
21 22 1 0
18 21 1 0
11 13 2 0
3 6 2 0
23 24 1 0
17 23 1 0
12 14 2 0
1 2 2 0
25 26 1 0
19 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 351.40Molecular Weight (Monoisotopic): 351.1471AlogP: 4.10#Rotatable Bonds: 6Polar Surface Area: 49.69Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.74CX LogD: 3.74Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.50Np Likeness Score: -0.13
References 1. Martel-Frachet V, Kadri M, Boumendjel A, Ronot X.. (2011) Structural requirement of arylindolylpropenones as anti-bladder carcinoma cells agents., 19 (20): [PMID:21908193 ] [10.1016/j.bmc.2011.08.015 ] 2. Valdameri G, Gauthier C, Terreux R, Kachadourian R, Day BJ, Winnischofer SM, Rocha ME, Frachet V, Ronot X, Di Pietro A, Boumendjel A.. (2012) Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity., 55 (7): [PMID:22449016 ] [10.1021/jm2016528 ]